Ani Pharmaceuticals (ANIP) Research & Development (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Research & Development of $10.6 million for Q1 2026, down 13.55% sequentially from $12.3 million in Q4 2025, and little changed YoY from $10.6 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Research & Development (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Research & Development for 17 years, with the latest figure at $10.6 million in Q1 2026.
- Quarterly Research & Development changed 0.34% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.7 million (up 15.83% YoY) and the FY2025 annual result came in at $51.7 million, up 15.89% from the prior year.
- Research & Development fell to $10.6 million in Q1 2026 per ANIP's latest filing, from $12.3 million in the prior quarter.
- Over five years, Research & Development peaked at $16.6 million in Q4 2024 and troughed at $4.2 million in Q2 2022.
- A 5-year average of $9.6 million and a median of $10.1 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development surged 211.77% in 2022, then slipped 26.34% in 2025.
- Over 5 years, Research & Development stood at $5.2 million in 2022, then jumped by 88.95% to $9.9 million in 2023, then soared by 68.7% to $16.6 million in 2024, then slipped by 26.34% to $12.3 million in 2025, then fell by 13.55% to $10.6 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $10.6 million, $12.3 million, and $12.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 14.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.75 Mn |
| Mar 31, 2026 | 10.60 Mn |
| Dec 31, 2025 | 12.26 Mn |
| Sep 30, 2025 | 12.30 Mn |
| Jun 30, 2025 | 16.54 Mn |
| Mar 31, 2025 | 10.56 Mn |
| Dec 31, 2024 | 16.65 Mn |
| Sep 30, 2024 | 10.13 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 10.51 Mn |
| Dec 31, 2023 | 9.87 Mn |
| Sep 30, 2023 | 11.12 Mn |
| Jun 30, 2023 | 7.37 Mn |
| Mar 31, 2023 | 5.92 Mn |
| Dec 31, 2022 | 5.22 Mn |
| Sep 30, 2022 | 7.66 Mn |
| Jun 30, 2022 | 4.17 Mn |
| Mar 31, 2022 | 5.27 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 2.46 Mn |